43 : 315319 Edwards R, Peet M, Shay J, Horrobin D
The rest of the outcome variables, nutritional status, body composition, biochemical data, and cognitive function, did not show any significant differences between the L-carnitine and placebo groups in the percent of mean changes in the intervention period
Clinical evidence: Reference the relevant trials from the FDA Profile section below: STEP 1 for weight management, SELECT for cardiovascular risk reduction, ESSENCE for MASH, STEP UP for the higher-dose 7.2 mg option, or OASIS 4 for the oral formulation
Davinelli, S
Another factor: newer drug formulations and biologics enter the market as injectables, and manufacturers tend to release pill versions later